Harvard Medical SchoolGrowing DNA StrandsHarvard Medical SchoolSynthetic biologists and nanobiologists are repurposing DNA as a smart and stable self-assembling material to build nanofactories, drug-delivering nanostructures and molecular devices that … Continue reading
Harvard Medical SchoolGrowing DNA StrandsHarvard Medical SchoolSynthetic biologists and nanobiologists are repurposing DNA as a smart and stable self-assembling material to build nanofactories, drug-delivering nanostructures and molecular devices that … Continue reading
IPO Education Foundation Honors CRISPR-Cas9 Innovators as Inventors of the YearPR Newswire (press release)WASHINGTON, Nov. 7, 2017 /PRNewswire/ — Intellectual Property Owners Education Foundation (IPOEF) is pleased to announce that its 44th Inventor o… Continue reading
IPO Education Foundation Honors CRISPR-Cas9 Innovators as Inventors of the YearMarkets InsiderWASHINGTON, Nov. 7, 2017 /PRNewswire/ — Intellectual Property Owners Education Foundation (IPOEF) is pleased to announce that its 44th Inventor of the Year … Continue reading
Lab-grown leather and spider silk are the future of your wardrobeMassiveA San Francisco synthetic biology incubator, IndieBio, hosts startups like Mycoworks, which is making a fungus-based alternative to leather, and BioLoom, which claims to grow cotto… Continue reading
OncLiveImmunotherapy Continues to Impress in GU MalignanciesOncLiveSingle-agent immunotherapy continues to demonstrate durable responses in patients with urothelial carcinoma, and now, combination regimens are showing efficacy in both urothelial carcin… Continue reading
Health24Does Gut Flora Impact the Response to Cancer Immunotherapy?MedPage TodayIn 112 melanoma patients undergoing anti-PD-1 immunotherapy, those with a high diversity of gut microbes had not yet reached median progression-free survival (PFS) after ne… Continue reading
|
Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels that Feed …
Business Wire (press release) To the company’s knowledge, this is the first polyvalent immunotherapy cleared by the FDA that targets the blood vessels that feed cancer. ValloVax was inspired by the original research of Dr. Valentin Ivanovich Govallo who observed tumor regression of … |